| DC Field | Value | Language |
|---|
| dc.contributor.author | Batishcheva, G. A. | - |
| dc.contributor.author | Zolotukhina, Ya. V. | - |
| dc.contributor.author | Shishkina, V. V. | - |
| dc.contributor.author | Khoroshikh, N. V. | - |
| dc.contributor.author | Samoylenko, T. V. | - |
| dc.date.accessioned | 2026-10-12T13:32:47Z | - |
| dc.date.available | 2026-10-12T13:32:47Z | - |
| dc.date.issued | 2026 | - |
| dc.identifier.citation | Efficacy of micronized progesterone-based preparations used to prevent placental insufficiency: an experimental study / G.A. Batishcheva, Ya.V. Zolotukhina, V.V. Shishkina [et al.] // Research Results in Pharmacology. - 2026. - Vol.12, №1.-P. 80-94. - DOI: 10.18413/rrpharmacology.12.1030. - Refer.: p. 92-93. | ru |
| dc.identifier.uri | http://dspace.bsuedu.ru/handle/123456789/67098 | - |
| dc.description.abstract | Progestogen-based drugs have anti-ischemic, antispasmodic, and immunomodulatory effects. Therefore, studying the effect of micronized progesterone (MP) on the inflammatory process in the placenta is of great importance | ru |
| dc.language.iso | en | ru |
| dc.subject | medicine | ru |
| dc.subject | pharmacology | ru |
| dc.subject | pregnancy | ru |
| dc.subject | micronized progesterone | ru |
| dc.subject | newborns | ru |
| dc.subject | placental insufficiency | ru |
| dc.title | Efficacy of micronized progesterone-based preparations used to prevent placental insufficiency: an experimental study | ru |
| dc.type | Article | ru |
| Appears in Collections: | Vol. 12, № 1
|
